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 he Agency for Healthcare Research and Quality
(AHRQ) has focused on building and supporting learn-
ing health systems. AHRQ defines a learning health sys-
tem as a system in which “internal data and experience are
systematically integrated with external evidence, and that
knowledge is put into practice.”1 AHRQ adds that, as a re-
sult of this use of experience and knowledge, “patients get
higher quality, safer, more efficient care, and health care de-
livery organizations become better places to work.”1 AHRQ
has commissioned several agencywide initiatives to explore
how its work can be more relevant to leaders, embedded
researchers, and change agents in health care delivery or-
ganizations striving to become learning health systems. 1–3
Among these initiatives is the AHRQ Evidence-based Prac-
tice Center (EPC) Program. 
Despite a growing number of models to improve the dis-
semination and implementation of research findings, 4 the
amount of time it currently takes to translate evidence into
practice is too long. 5,6 Decision makers within health sys-
tems may have different evidence needs than other stake-
holders (for example, clinical professional societies, prac-
ticing clinicians), and they likely need additional products
to help them incorporate and use findings from systematic
evidence reviews in their routine operations (hereafter, we
refer to these types of products as translational products ).
For example, clinical professional organizations routinely
use systematic reviews to inform the development of their
guidelines. However, systematic reviews are not frequently
used by health care managers and policy makers in decision
making and may need to be in more succinct or alternative
formats. 7,8 Health systems are also still looking for ways to
effectively combine their locally generated data with criti-
cally appraised external evidence. 9 The core focus of EPCs is
to synthesize evidence using rigorous scientific methods, 10
but the EPC Program recognizes that not everyone has time
to read a full evidence review and that an evidence review
alone will not change practice. 
To advance this goal, the EPC Program has taken a mul-
tipronged approach. 11 In 2018, EPCs conducted nine pi-
lot projects to develop new and innovative translational1553-7250/$-see front matter 
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 products for health systems. 12,13 An overview of the pilot
projects 14 and the results of other projects are described in
detail in other articles in this series. 15–17 AHRQ gave the
EPCs flexibility in the design and evaluation of their prod-
ucts. Each EPC could select its own report topic, often in
consultation with its partner health system, 14 and develop
a product it believed would be responsive to the needs of its
partner health system. Because decisions are made through-
out multiple levels of the health system, the EPCs also had
the flexibility to select specific partners within the health
system. The products developed for the pilots ranged from
dissemination products (for example, short summaries), to
interactive presentations of the data, to implementation
products (for example, clinical pathway). The content each
product pulled from the EPC evidence reviews varied de-
pending on the intent of the product. More information
about each EPC pilot, including examples of the products,
are available on the AHRQ website. 12 
In a parallel effort, the AHRQ EPC Program has con-
vened a Learning Health Systems Panel to hear directly
about the needs of learning health systems clinical leaders
and to guide the development, implementation, and evalu-
ation of the use of different translational products. 18 
The purpose of this paper is to (1) describe AHRQ’s
Learning Health Systems Panel, and (2) report on some of
the early findings from the panel about challenges health
system clinical leaders face in adopting evidence-based prac-
tices, and their feedback on the utility of the EPC pilots
of the translational products. These findings can inform
the EPC Program – and other organizations that produce
evidence reviews – to help health systems use evidence to
inform operational decisions about design and delivery of
health-related services. 
PANEL ORGANIZATION AND COMPOSITION 
AHRQ’s Learning Health Systems Panel is managed by
the American Institutes for Research (AIR) and its part-
ners from Kaiser Permanente (KP) Northwest Region and
the University of California, San Francisco (UCSF). The
AIR team engaged two national leaders with deep field con-
nections to recruit a representative panel of key stakehold-
ers internal to delivery systems who are intended users of
the AHRQ evidence reports. Lucy Savitz, PhD, MBA, vice
president for Health Research, KP; and Andrew Bindman,
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 MD, professor of medicine, epidemiology, and biostatistics,
UCSF, identified a group that represents a cross-section of
health systems in terms of geography, size, services offered,
and teaching status. Overall, these health systems have some
experience using evidence to improve care, and many of
them participate in collaboratives and research networks
(for example, the High Value Healthcare Collaborative) to
contribute to and disseminate evidence. Table 1 provides a
descriptive list of the panel members together with associ-
ated organizational affiliations and attributes. 
OBJECTIVES OF THE FIRST LEARNING HEALTH 
SYSTEMS PANEL MEETING 
In January 2019 AHRQ convened the Learning Health Sys-
tems Panel for its first in-person meeting. The meeting ob-
jectives were to gather feedback from the panel members
on (1) challenges to implementing evidence in their health
systems and (2) the utility of a set of EPC translational
products that were developed through pilot projects to in-
crease health systems’ use of evidence from systematic re-
views. 15–17 
During the meeting, panel members discussed their ex-
periences using evidence, including evidence from system-
atic reviews. Through a facilitated discussion led by Savitz
and Bindman, they described the key challenges they face
related to embedding external evidence into—and poten-
tially changing—their existing clinical workflows. 
Next, Jeanne-Marie Guise, MD, MPH, director, Sci-
entific Resource Center for the EPC Program, provided a
brief summary of the overall goal of each of the EPC pi-
lot projects to develop, test, and evaluate a new transla-
tional product in collaboration with a partnering health sys-
tem. The summary presentation included screenshots of the
products. Guise described their intent and findings from
the evaluation of each pilot, as well as overall conclusions
across the pilots. Panel members discussed these products
and then participated in an activity in which they ranked
the top three translational products based on their expected
usefulness for translating, sharing, and facilitating use of
evidence from systematic reviews within their health sys-
tem (see Table 2 ). Panel members then discussed the results
of the ranking process and what they found helpful or not
helpful about the products. 
Based on an audio recording and notes from the meet-
ing, the AIR team created a meeting summary to describe
the discussions. This summary, which was reviewed by
AHRQ and shared with the panel members, was used as
the basis for the key findings for this article. 
KEY FINDINGS 
Challenges Health Systems Face in Adopting 
Evidence-Based Practices 
Several issues and unmet needs emerged from the panel
discussion about the challenges of adopting evidence-based
practices within the panel members’ health systems: • Lack of evidence addressing health system opera-
tional issues to identify and implement the most effec-
tive care delivery models. A common “operational issue”
shared by the panel relates to how to align internal evi-
dence generated by the learning health system with ex-
ternal evidence to help inform if, how, and in what pa-
tient groups to implement an intervention or treatment.
For example, internal evidence might include informa-
tion gathered from a health system’s internal electronic
health record (EHRs) about their patients, whereas ex-
ternal evidence might include synthesized information
from a systematic evidence review. 
• Need for strategies to overcome barriers clinicians
and other frontline staff face in implementing evi-
dence due to two primary factors: (1) the strength and
clarity of available evidence may be weak and/or scant,
and (2) the perception that the evidence does not apply
to their own patient population, particularly vulnerable
populations (such as patients with diabetes and food
insecurity). 
• Implementing evidence-based changes into existing
workflows is complex, beginning with identifying who
is responsible for implementing the change, how to com-
municate the change, and how to operationalize the
change in clinical decision support systems. 
• Need to distill and communicate actionable evidence
to clinicians and frontline staff that meet them where
they are rather than providing broad clinical decision
support. Findings from an evidence review can be
complex. But health systems want to be able to easily
understand and use the findings to inform and change
practice. 
• Need for providing the most timely and current ev-
idence because clinicians want the most up-to-date ev-
idence in clinical decision support tools in EHRs. Evi-
dence reviews, particularly systematic reviews, often take
more than a year to complete. They lack the timeli-
ness and currency that clinicians desire, and the growing
number of retractions from individual studies that may
not be incorporated into the product is concerning. 
Feedback on Utility of EPC Translational Products 
Overall, the panel members thought some of the EPC trans-
lational products ( Table 2 ) would be helpful to health sys-
tems. The panel members selected a dissemination, in-
teractive data visualization, and implementation product
as the top three products prioritized through the ranking
exercise—demonstrating the value of a broad range of ap-
proaches for various users within the health system. The ra-
tionale for choosing these three products is described below:
• One- and Three-Page Summaries: The summaries
used different design elements (use of color, placement
of program logos, and others), and types of information
included (qualitative vs. quantitative) for the purpose of
comparing the benefits and harms of treatment options.
Volume 45, No. 11, November 2019 775 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Panel members liked that the summaries were short and
easy to disseminate within their organization. The con-
tent was accessible and could be read and grasped in
a short amount of time. One panel member shared,
“That’s something I can read quickly and I can forward
quickly to my cardiology service line lead or my ortho-
pedic service lead with confidence they’d probably look
at it. They wouldn’t look at the 1,400-page report. So
the access and usability and the fact that I could scan
that in 10 to 15 minutes and glean the key insights.”
• MAGICapp and Tableau Data Visualization: MAGI-
Capp and Tableau are two software programs that allow
users to create visual presentations of data (for example,
from systematic reviews). The specific types of visualiza-tions vary depending on the program. MAGICapp al-
lowed users to see summary results at a high level and
to drill down into specific information as needed. The
Tableau visualization allowed the user to slice and dice to
see specific types of information as desired (for example,
by dividing the data into subgroups corresponding to
interests). The panel liked the visual, interactive nature
of the product, specifically the ability to drill down to
various levels of evidence. They also found the overview
of the evidence to be useful and appreciated that they
could easily share the data with colleagues to facilitate
conversations and decision making. One panel member
shared, “You can get the overview and also do the drill-
down to the various levels of evidence. It can be very
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 powerful to share with people and you can get to their
level. Allows you to be very precise in how you use the
data.” Finally, several panel members were familiar with
Tableau, which increased its appeal. 
• Clinical Encounter and Health System Decision Aid:
The health care system decision aid included informa-
tion on costs, feasibility, and other implementation con-
siderations that are not typically included in EPC re-
views. The encounter decision aid included information
pertaining to the benefits and harms of treatment op-
tions to facilitate shared decision making. Panel mem-
bers felt that the clinical encounter aid distills informa-
tion in a simple manner accessible to both the clinician
and patient, and thus can be used to facilitate a discus-
sion. They also remarked that the format of the product
is visually appealing. One panel member shared, “This
mental health example gives you pause to look at it. The
color and plus marks [notations used to display reduc-
tion in symptoms and improvement in day-to-day func-
tion] really give you that visualization, and I can easily
turn this around from the ambulatory setting to the pa-
tient. It’s not only a clinical decision-making tool but
can also double as a shared decision-making tool.”
Panel members shared the following reasons for not pro-
viding higher rankings for some of the other reviewed trans-
lation products: 
• Feeling overwhelmed and uncertain of the usefulness
of the product. For example, panel members perceived
one of the interactive products as having an overwhelm-
ing number of Web links, and they did not think leaders
in their health system would click on any of the links.
They were not sure that the leaders’ questions would be
answered by clicking on the links. 
• Concern that the product could not be used in their
setting. For example, with a dissemination product that
relied on an in-person delivery mode, the panel members
noted that it is difficult to get attendance at seminars.
One panel member shared, “The only times we can do
. . . seminars are early morning or after work, so the only
other time we could to do it is during lunchtime. But
patient care can bleed into lunch time. The only way we
can get people into a lunchtime situation is if we buy and
bribe with food. Also, we’ve had low attendance unless
time is held.”
Implications 
Overall, the feedback from the Learning Health Systems
Panel members reinforced previous findings about chal-
lenges faced by health systems in translating evidence into
practice 6,7,19–22 and highlighted their particular needs for
timely, concise, and actionable evidence that can be easily
operationalized into existing clinical workflows. Thus, al-
though they found value in some of the translational prod-
ucts, even the new products developed under the pilots leave
some challenges unaddressed, suggesting a need for furtherimprovements. The feedback highlights several key consid-
erations for developing evidence reviews and translational
products that are both relevant and actionable for health
systems. Specifically, the panel expressed a need for the fol-
lowing: 
• Clear, Concise, Actionable Data to Support Decision
Making at Various Levels: Health systems need evi-
dence that is summarized and presented in ways that
support decision making for leaders, clinicians and other
frontline staff, and patients. 
• Products that Combine Local Data with Findings
from Evidence Reports: Health systems need transla-
tional products that allow them to integrate their own
evidence—generated from their local patient population
data—within the context of the findings of an evidence
review. 
• Easily-Accessible Translational Products: Health sys-
tems need products that (1) can be easily shared across
their system, (2) primarily include data in the form of
graphs and tables, and (3) offer users the ability to inter-
act with the data to drill down as needed. 
NEXT STEPS 
The AHRQ EPC Program will use the panel’s feedback as
part of its ongoing efforts to increase usability and accessi-
bility of EPC evidence reviews and translational products
for health systems. The EPC Program is further developing
two of the products from the pilots: the one- and three-page
summaries and MAGICapp and Tableau data visualization.
AHRQ is exploring the use of a brief summary to highlight
key findings with future reports and expanding functional-
ity of the AHRQ website to include interactive Web-based
visualizations of evidence reviews that will allow readers to
select drill-down options most relevant to their information
needs. 
In addition, the EPC Program plans to develop at least
one new translational product that health systems can use
to assess and integrate EPC evidence review findings into
clinical care and routine operations. This might include
a product that provides summaries specifically tailored for
key users of evidence within health systems, or provides ex-
panded contextual information (such as implementation re-
sources and feasibility factors) that learning health systems
need to assess the business case for implementing an inter-
vention. A new product(s) will build on key components
of the EPC pilots’ translational products found to be most
useful to the Learning Health Systems Panel. The team will
use an iterative process to develop the new product(s) to en-
sure that it resonates with and will be useful for the health
systems. 
Each Learning Health Systems Panel member will
implement and evaluate one of these products. Panel
members will be able to select the product: either one of
the new products developed by the AIR team or one of the
Volume 45, No. 11, November 2019 777 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 existing EPC products, which includes products from these
pilots. Panel members will serve as local implementation
champions and receive support and guidance from the AIR
team to tailor the implementation to their local context and
needs. Through the Learning Health Systems Panel project,
the AIR team will also conduct a process evaluation of the
implementation to inform the refinement of the products
and assess the acceptability, adoption, appropriateness,
feasibility, fidelity, implementation cost, penetration, and
sustainability. 20 These domains are based on two widely
respected implementation and evaluation frameworks,
combined into a refined Consolidated Framework for Im-
plementation Research model. 23,24 The primary data source
for the evaluation will be interviews with health system
stakeholders who are involved with the implementation. 
CONCLUSION 
The AHRQ EPC Program is committed to helping health
systems use information from evidence reviews to inform
operational decisions. As the program continues these ef-
forts, it will actively disseminate this work and make its
materials publicly available 25 so that other health systems
can use the products and materials in their own settings to
improve the delivery and quality of patient care. 
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